Evaluating Clinical Trial Experiences of Individuals With Congestive Heart Failure - Trial NCT05516290
Access comprehensive clinical trial information for NCT05516290 through Pure Global AI's free database. This phase not specified trial is sponsored by Power Life Sciences Inc. and is currently Not yet recruiting. The study focuses on Congestive Heart Failure. Target enrollment is 500 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Power Life Sciences Inc.
Timeline & Enrollment
N/A
Sep 18, 2022
Sep 18, 2024
Primary Outcome
Number of patient decides to enroll in a congestive heart failure clinical trial,Rate of patients who remain in a congestive heart failure clinical trial to trial completion
Summary
Clinical trial participation has always been substantially skewed toward certain demographic
 groups. However, there has been little study on whether trial qualities impact participation
 in either a positive or negative way. The goal of this research is to identify the
 characteristics that consistently restrict patients' ability to participate in or complete a
 trial in which they were initially interested. This data will be evaluated via a number of
 demographic lenses in order to find trends that could benefit future Congestive Heart Failure
 sufferers.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05516290
Non-Device Trial